Skip to main content

Aleria Biodevices Receives Capital Injection of One Million Euros

By 21 de November de 2008November 18th, 2020No Comments
< Back to news

Aleria Biodevices Receives Capital Injection of One Million Euros

Aleria Biodevices, which is a spin-off of the Bioengineering Institute of Catalonia (IBEC) located at the Barcelona Science Park, announces the successful completion of its first round of funding. Aleria has received one million euros to develop its technology in the area of biomedical instrumentation.

The project counts on the participation of the Centre for Industrial Technology Development (CDTI), which has contributed half of the capital, the venture-capital firm Inveready Seed Capital, La Caixa’s venture-capital group Caixa Capital Semilla, and other private investors.

Aleria Biodevices, a new member of the PCB-Santander Bioincubator, develops and commercialises medical instrumentation and microdevices for new treatments and clinical diagnostics. The company’s first product line is a range of plastic devices and instruments that work simply and economically to enable the measurement of electrical activity generated by neurons in vitro.

Obtaining electrophysiological measurements in neuronal cultures is necessary in a wide range of research areas in the neurosciences, and it is fundamental to the development of new drugs aimed at the treatment of complex diseases such as epilepsy and Alzheimer’s.